Literature DB >> 28356225

miR-532 promoted gastric cancer migration and invasion by targeting NKD1.

Shaobo Hu1, Qichang Zheng1, Heshui Wu2, Chunyou Wang2, Tao Liu2, Wei Zhou3.   

Abstract

Gastric cancer is one of the most common human malignant neoplasms, especially in China, its regulatory mechanism is important to develop new therapy approaches. miRNAs have been demonstrated to regulate gastric cancer progression. We found miR-532 was overexpressed in gastric cancer tissues and cells. Wound healing and transwell assay revealed that its overexpression promoted gastric cancer cell migration and invasion, its knockdown inhibited gastric cancer cell migration and invasion. Wnt/β-catenin antagonist naked cuticle homolog 1 (NKD1) was the target of miR-532, miR-532 inhibited NKD1 expression. TOP/FOP luciferase activity analysis suggested miR-532 also increased Wnt/β-catenin pathway activity. Overexpression miR-532 and NKD1 inhibited gastric cancer cell migration and invasion, consistent with miR-532 knockdown. These findings revealed miR-532 promoted gastric cancer cell migration and invasion through inhibiting NKD1 and activated Wnt/β-catenin pathway. We provide a potential target for gastric cancer therapy.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Gastric cancer, NKD1; Invasion; Migration; miR-532

Mesh:

Substances:

Year:  2017        PMID: 28356225     DOI: 10.1016/j.lfs.2017.03.019

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  25 in total

1.  MiR-214-3p regulates the viability, invasion, migration and EMT of TNBC cells by targeting ST6GAL1.

Authors:  Yun Tao; Zhijing Zhao; Junfeng Ma; Liying Dong; Ying Liang; Siqi Li; Ying Mao; Yan Li; Yi Zhang
Journal:  Cytotechnology       Date:  2019-11-08       Impact factor: 2.058

2.  Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis.

Authors:  Youchun Ye; Hongfeng Li; Jia Bian; Liangfei Wang; Yijie Wang; Hui Huang
Journal:  Int J Gen Med       Date:  2021-11-30

3.  Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis.

Authors:  Sen Hong; Qiuxia Li; Ying Yang; Deqian Jing; Fengbo Zhu
Journal:  Mol Biotechnol       Date:  2021-09-22       Impact factor: 2.695

4.  MicroRNA-19a-3p Acts as an Oncogene in Gastric Cancer and Exerts the Effect by Targeting SMOC2.

Authors:  Hui Xu; Guochun Lu; Shengkun Zhou; Fu Fang
Journal:  Appl Biochem Biotechnol       Date:  2022-05-11       Impact factor: 3.094

5.  MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.

Authors:  Lei Hongwei; Li Juan; Xu Xiaoying; Fan Zhijun
Journal:  Cytotechnology       Date:  2022-06-06       Impact factor: 2.040

6.  microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.

Authors:  Ying Song; Yue Zhao; Xiangfu Ding; Xiaodong Wang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

7.  miR-3178 as a prognostic indicator and tumor suppressor of gastric cancer.

Authors:  Jin-Cheng Wu; Zhao-Hui Liu; Xiaomei Ding; Rui-Sheng Ke
Journal:  Ir J Med Sci       Date:  2021-02-05       Impact factor: 1.568

8.  The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.

Authors:  Yuting He; Jianming Zhou; Qinsi Wan
Journal:  Invest New Drugs       Date:  2021-01-06       Impact factor: 3.850

9.  miR-504 Promoted Gastric Cancer Cell Proliferation and Inhibited Cell Apoptosis by Targeting RBM4.

Authors:  Yi Zhang; Hongmei Yong; Jing Fu; Guangyi Gao; Huichang Shi; Xueyi Zhou; Mingsheng Fu
Journal:  J Immunol Res       Date:  2021-06-04       Impact factor: 4.818

10.  Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer.

Authors:  Jiao Li; Shan Tian; Yingyun Guo; Weiguo Dong
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.